ConductScience.org, home

Trial · NCT00661037

SAFEty of Two Strategies of ICD Management at Implantation

NCT00661037, Completed, Boston Scientific Corporation; results first posted 2017-06-20

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. SAFEty of Two Strategies of ICD Management at Implantation. Trials, record NCT00661037. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00661037

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
SAFEty of Two Strategies of ICD Management at Implantation
NCT number
NCT00661037
Status
Completed
Enrollment
2,120 participants, actual
Lead sponsor
Boston Scientific Corporation
Conditions
Ventricular Fibrillation, Ventricular Flutter, Sudden Cardiac Death
Interventions
Implantable defibrillator, Implantable defibrillator
First posted
2008-04-18
Last updated
2017-07-21
Results first posted
2017-06-20

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of Participants With Severe Intra-operative Complications at ICD Implant and/or Events at Follow up2 years
* Severe implant-related\* complications at ICD implants among the following: * Survival from cardiopulmonary arrest due to VF requiring 3 or more consecutive external shocks for termination or due to electro-mechanical dissociation. * Transient ischemic attack or stroke, * Cardiogenic shock, * Pulmonary edema, * Embolic events, * Anoxic coma * Pericardial tamponade * Death. * Events at follow up: * Sudden cardiac death (defined as witnessed unexpected death occurring \<1 hour from symptoms onset or unwitnessed during sleep) * Resuscitation after ineffective documented appropriate ICD shocks * Implant related events are considered as those listed above, occurring during the implant procedure in the timeframe betweend device poket insertion and patient exit from the cath-lab, as well as those events occurring after the patient exit from the cath-lab that, after review from the event adjudication committee, have been classified as related to the implant procedure.
SecondarySevere Intra-operative ComplicationsAcute (ICD implant)including: cardiopulmonary arrest, transient ischemic attack or stroke, cardiogenic shock, pulmonary edema, embolic event, anoxic coma, pericardial tamponade,death
SecondarySudden Cardiac Death at Follow up or Resusciation After Ineffective Documented Appropriate ICD Shocks at Follow up2 years

Outcomes3

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Participants With Severe Intra-operative Complications at ICD Implant and/or Events at Follow up2 yearsParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYSevere Intra-operative ComplicationsAcute (ICD implant)ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYSudden Cardiac Death at Follow up or Resusciation After Ineffective Documented Appropriate ICD Shocks at Follow up2 yearsParticipantsCOUNT_OF_PARTICIPANTS

Results by group6

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants With Severe Intra-operative Complications at ICD Implant and/or Events at Follow upVF Induction18Participants
Number of Participants With Severe Intra-operative Complications at ICD Implant and/or Events at Follow upno VF Induction16Participants
Severe Intra-operative ComplicationsVF Induction8Participants
Severe Intra-operative Complicationsno VF Induction4Participants
Sudden Cardiac Death at Follow up or Resusciation After Ineffective Documented Appropriate ICD Shocks at Follow upVF Induction10Participants
Sudden Cardiac Death at Follow up or Resusciation After Ineffective Documented Appropriate ICD Shocks at Follow upNo- VF Induction12Participants

Participant flow10

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDVF Induction836
Overall StudySTARTEDno VF Induction1,284
Overall StudyWitdrawnVF Induction47
Overall StudyWitdrawnno VF Induction68
Overall StudyDeathsVF Induction108
Overall StudyDeathsno VF Induction188
Overall StudyCOMPLETEDVF Induction682
Overall StudyCOMPLETEDno VF Induction1,027
Overall StudyNOT COMPLETEDVF Induction154
Overall StudyNOT COMPLETEDno VF Induction257

Adverse events8

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherAE - Adverse Events (Non serious / non device related)Cardiac disordersVF Induction4283653
otherAE - Adverse Events (Non serious / non device related)Cardiac disordersno VF Induction441,28453
otherADE - non serious adverse device effectsCardiac disordersVF Induction78836126
otherADE - non serious adverse device effectsCardiac disordersno VF Induction461,28470
seriousSAE-serious adverse eventsCardiac disordersVF Induction146836222
seriousSAE-serious adverse eventsCardiac disordersno VF Induction1331,284205
seriousSADE - serious adverse device effectsCardiac disordersVF Induction63836107
seriousSADE - serious adverse device effectsCardiac disordersno VF Induction441,28474

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityVF Induction108836
Total, all-cause mortalityno VF Induction1881,284
Total, other adverse eventsVF Induction120836
Total, other adverse eventsno VF Induction901,284
Total, serious adverse eventsVF Induction209836
Total, serious adverse eventsno VF Induction1771,284

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
22858384DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons5

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
VF Induction vs No- VF Induction: Sudden Cardiac Death at Follow up or Resusciation After Ineffective Documented Appropriate ICD Shocks at Follow upTrial comparisons
VF Induction vs no VF Induction: Severe Intra-operative ComplicationsTrial comparisons
VF Induction vs no VF Induction: deaths from any causeTrial comparisons
VF Induction vs no VF Induction: Number of Participants With Severe Intra-operative Complications at ICD Implant and/or Events at Follow upTrial comparisons
VF Induction vs no VF Induction: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00661037

GET https://conductscience.org/api/trials/v1/NCT00661037/registered